CBD-Intel

CBD in Libya

All content relating to Libya can be found on this page. It contains everything from our interactive, user-friendly trackers and databases, to our full-length regulatory and market reports, and our extensive business and regulatory news briefings.

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions